Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology t (Q44592606)
Jump to navigation
Jump to search
scientific article published in October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology t |
scientific article published in October 2003 |
Statements
Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial) (English)
L Zelek
R Bugat
D Cherqui
G Ganem
P Valleur
R Guimbaud
O Dupuis
T Aziza
P L Fagniez
J Auroux
H Kobeiter
C Tayar
A C Braud
E Haddad
A Piolot
M Buyse